Vanguard Group Inc Geo Vax Labs, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.51 - $0.62 $1,296 - $1,576	-2,542 Reduced 0.35%	728,443 $371,000
Q4 2022 Feb 10, 2023	BUY	$0.55 - $0.89 $99,560 - $161,106	181,019 Added 32.91%	730,985 $460,000
Q3 2022 Nov 14, 2022	BUY	$0.4 - $1.72 $116,480 - $500,864	291,200 Added 112.53%	549,966 $600,000
Q4 2021 Feb 14, 2022	SELL	N/A	-397 Reduced 0.15%	258,766 $937,000
Q3 2021 Nov 12, 2021	BUY	N/A	2,542 Added 0.99%	259,163 $1.12 Million

Q2 2021 Aug 13, 2021	BUY	N/A	256,621 New	256,621 $1.28 Million

Ticker GOVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,744,000
Market Cap $69.3M
Description
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhag...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.